Deinove Is A French Biotechnology Company Based In Montpellierspecializing In The Exploration Of Microbial Biodiversitythe Company Focuses On Addressing Antimicrobial Resistanceamrby Discovering And Developing New Antimicrobial Therapies And Industrial Bioproduction Solutionsdeinove Is Listed On Euronext Growth Paris And Employs Around 45 50 Staff Memberscollaborating With Various Academicindustrialand Institutional Partners Worldwide The Companyae S Primary Offerings Include The Development Of Antibioticsantifungalsantiviralsand Antiparasitics Aimed At Combating Multidrug Resistant Infectionsdeinove Also Maintains A Proprietary Library Of 10 000 Rare Bacterial Strains And Engineers Bacteria To Produce Complex Compounds That Are Difficult To Synthesize Chemicallythis Integrated Approach Combines Strain Discoverybioengineeringand Clinical Developmentpositioning Deinove As A Key Player In The Fight Against Amr
